These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18291676)

  • 1. The 5-HT2A receptor binding pattern in the human brain is strongly genetically determined.
    Pinborg LH; Arfan H; Haugbol S; Kyvik KO; Hjelmborg JV; Svarer C; Frokjaer VG; Paulson OB; Holm S; Knudsen GM
    Neuroimage; 2008 Apr; 40(3):1175-80. PubMed ID: 18291676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients.
    Erritzoe D; Rasmussen H; Kristiansen KT; Frokjaer VG; Haugbol S; Pinborg L; Baaré W; Svarer C; Madsen J; Lublin H; Knudsen GM; Glenthoj BY
    Neuropsychopharmacology; 2008 Sep; 33(10):2435-41. PubMed ID: 18288096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and Environmental Influences on Regional Brain Uptake of 18F-FDG: A PET Study on Monozygotic and Dizygotic Twins.
    Watanabe S; Kato H; Shimosegawa E; Hatazawa J
    J Nucl Med; 2016 Mar; 57(3):392-7. PubMed ID: 26585060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET.
    Ettrup A; Palner M; Gillings N; Santini MA; Hansen M; Kornum BR; Rasmussen LK; Någren K; Madsen J; Begtrup M; Knudsen GM
    J Nucl Med; 2010 Nov; 51(11):1763-70. PubMed ID: 20956470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans.
    Erritzoe D; Holst K; Frokjaer VG; Licht CL; Kalbitzer J; Nielsen FA; Svarer C; Madsen J; Knudsen G
    J Neurosci; 2010 Mar; 30(9):3391-7. PubMed ID: 20203198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.
    Hansen HD; Ettrup A; Herth MM; Dyssegaard A; Ratner C; Gillings N; Knudsen GM
    Synapse; 2013 Jun; 67(6):328-37. PubMed ID: 23390031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables.
    Adams KH; Pinborg LH; Svarer C; Hasselbalch SG; Holm S; Haugbøl S; Madsen K; Frøkjaer V; Martiny L; Paulson OB; Knudsen GM
    Neuroimage; 2004 Mar; 21(3):1105-13. PubMed ID: 15006678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain.
    Borg J; Cervenka S; Kuja-Halkola R; Matheson GJ; Jönsson EG; Lichtenstein P; Henningsson S; Ichimiya T; Larsson H; Stenkrona P; Halldin C; Farde L
    Mol Psychiatry; 2016 Aug; 21(8):1077-84. PubMed ID: 26821979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A PET [18F]altanserin study of 5-HT2A receptor binding in the human brain and responses to painful heat stimulation.
    Kupers R; Frokjaer VG; Naert A; Christensen R; Budtz-Joergensen E; Kehlet H; Knudsen GM
    Neuroimage; 2009 Feb; 44(3):1001-7. PubMed ID: 19007894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low frontal serotonin 2A receptor binding is a state marker for schizophrenia?
    Rasmussen H; Frokjaer VG; Hilker RW; Madsen J; Anhøj S; Oranje B; Pinborg LH; Glenthøj B; Knudsen GM
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1248-50. PubMed ID: 27179966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-efficient and convenient synthesis of [(18)F]altanserin for human PET imaging by a new work-up procedure.
    Massarweh G; Kovacevic M; Rosa-Neto P; Evans AC; Diksic M; Schirrmacher R
    Appl Radiat Isot; 2009 Nov; 67(11):2040-3. PubMed ID: 19692252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography.
    Mintun MA; Sheline YI; Moerlein SM; Vlassenko AG; Huang Y; Snyder AZ
    Biol Psychiatry; 2004 Feb; 55(3):217-24. PubMed ID: 14744461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common HTR2A variants and 5-HTTLPR are not associated with human in vivo serotonin 2A receptor levels.
    Spies M; Nasser A; Ozenne B; Jensen PS; Knudsen GM; Fisher PM
    Hum Brain Mapp; 2020 Nov; 41(16):4518-4528. PubMed ID: 32697408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal assessment of cerebral 5-HT2A receptors in healthy elderly volunteers: an [18F]-altanserin PET study.
    Marner L; Knudsen GM; Haugbøl S; Holm S; Baaré W; Hasselbalch SG
    Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):287-93. PubMed ID: 18828013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subacromial Space Width: Does Overuse or Genetics Play a Greater Role in Determining It? An MRI Study on Elderly Twins.
    Gumina S; Arceri V; Fagnani C; Venditto T; Catalano C; Candela V; Nisticò L
    J Bone Joint Surg Am; 2015 Oct; 97(20):1647-52. PubMed ID: 26491128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.
    Hinz R; Bhagwagar Z; Cowen PJ; Cunningham VJ; Grasby PM
    J Cereb Blood Flow Metab; 2007 Jan; 27(1):161-72. PubMed ID: 16685260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial risk for mood disorder and the personality risk factor, neuroticism, interact in their association with frontolimbic serotonin 2A receptor binding.
    Frokjaer VG; Vinberg M; Erritzoe D; Baaré W; Holst KK; Mortensen EL; Arfan H; Madsen J; Jernigan TL; Kessing LV; Knudsen GM
    Neuropsychopharmacology; 2010 Apr; 35(5):1129-37. PubMed ID: 20043006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei.
    Adams KH; Hansen ES; Pinborg LH; Hasselbalch SG; Svarer C; Holm S; Bolwig TG; Knudsen GM
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):391-401. PubMed ID: 15801987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT2A receptor density is decreased in the at-risk mental state.
    Hurlemann R; Matusch A; Kuhn KU; Berning J; Elmenhorst D; Winz O; Kolsch H; Zilles K; Wagner M; Maier W; Bauer A
    Psychopharmacology (Berl); 2008 Jan; 195(4):579-90. PubMed ID: 17899021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.